MTOR and neoplasm: Particularly, highly phosphorylated RPS6KB1 (p-RPS6) and RPS6 (p-RPS6) were linked to noticeably lower overall survival rates, suggesting that mTOR pathway activation might be involved in tumor aggressiveness.